Literature DB >> 25023545

Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.

Wei-Hsun Chen1, Yen-Lin Huang, Yin-Kai Chao, Chi-Ju Yeh, Hsien-Kun Chang, Chen-Kan Tseng, Yun-Hen Liu.   

Abstract

OBJECTIVE: To investigate the prognostic significance of lymphovascular invasion (LVI) in patients with esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (nCRT).
METHODS: We retrospectively reviewed the charts of 416 consecutive patients with ESCC who underwent surgical resection following nCRT at the Chang Gung Memorial Hospital between 1998 and 2008. After exclusion of patients with non-R0 resection or showing no residual tumor (ypT0Nx), the histological tumor sections of 231 patients were reviewed for LVI. Univariate and multivariate analyses were used to identify the independent predictors of overall survival (OS).
RESULTS: LVI was observed in 85 patients (36.8 %). The presence of LVI was related to close circumferential resection margins (CRMs), a greater depth of invasion, poor tumor differentiation, and an increased occurrence of lymph node metastases (LNM). The 5 year OS was significantly lower (10 %) in patients with LVI than in those without (31 %; p < 0.001). By multivariate Cox regression analyses, LVI (hazard ratio [HR] 1.5; p = 0.002) and LNM (HR 1.6; p = 0.007) were identified as independent adverse prognostic factors for OS. The 5 year OS rates according to the number of risk factors present were 35, 21, 20, and 5 for LVI(-)LNM(-), LVI(+)LNM(-), LVI(-)LNM(+), and LVI(+)LNM(+) patients, respectively (p < 0.001).
CONCLUSIONS: The presence of LVI is independently associated with shorter OS in ESCC patients receiving nCRT. Links between LVI and LNM may provide new clues for the prognostic stratification of esophageal cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25023545     DOI: 10.1245/s10434-014-3881-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma.

Authors:  Haris Zahoor; James D Luketich; Benny Weksler; Daniel G Winger; Neil A Christie; Ryan M Levy; Michael K Gibson; Jon M Davison; Katie S Nason
Journal:  Am J Surg       Date:  2015-06-26       Impact factor: 2.565

2.  Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.

Authors:  Abhinav Dewan; S K Sharma; A K Dewan; Ruparna Khurana; Manoj Gupta; Anjali Pahuja; Himanshu Srivastava; Rupal Sinha
Journal:  J Gastrointest Cancer       Date:  2017-03

3.  Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy.

Authors:  Yoichi Hamai; Manabu Emi; Yuta Ibuki; Yuji Murakami; Ikuno Nishibuchi; Yasushi Nagata; Takaoki Furukawa; Tomoaki Kurokawa; Manato Ohsawa; Toru Yoshikawa; Morihito Okada
Journal:  Ann Surg Oncol       Date:  2020-05-13       Impact factor: 5.344

4.  PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.

Authors:  Keisuke Kurimoto; Masamichi Hayashi; Rafael Guerrero-Preston; Masahiko Koike; Mitsuro Kanda; Sho Hirabayashi; Hiroshi Tanabe; Nao Takano; Naoki Iwata; Yukiko Niwa; Hideki Takami; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Goro Nakayama; Hiroyuki Sugimoto; Tsutomu Fujii; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Epigenetics       Date:  2017-11-27       Impact factor: 4.528

5.  Lymphovascular invasion predicts disease-specific survival in node-negative esophageal squamous cell carcinoma patients after minimally invasive esophagectomy.

Authors:  Ying-Jian Wang; Xiao-Long Zhao; Kun-Kun Li; Xue-Hai Liu; Tao Bao; Wei Guo
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-01-19       Impact factor: 1.627

6.  The prognostic role of angiolymphatic invasion in N0 esophageal carcinoma: a meta-analysis and systematic review.

Authors:  An Wang; Yulong Tan; Yuyan Zhang; Dong Xu; Yuchao Fang; Xiaofeng Chen; Shaohua Wang
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

7.  Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.

Authors:  Bei Li; Xian-Ze Xiong; Yong Zhou; Si-Jia Wu; Zhen You; Jiong Lu; Nan-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

8.  Can Lymphovascular Invasion be Predicted by Preoperative Contrast-Enhanced CT in Esophageal Squamous Cell Carcinoma?

Authors:  Wei Chen; Yating Wang; Genji Bai; Chunhong Hu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

9.  A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma.

Authors:  Rongwei Ruan; Shengsen Chen; Yali Tao; Jiangping Yu; Danping Zhou; Zhao Cui; Qiwen Shen; Shi Wang
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Evaluating the eighth edition TNM staging system for esophageal cancer among patients receiving neoadjuvant therapy: A SEER study.

Authors:  Yonggang Yuan; Ge Ma; Xuelei Hu; Qingyuan Huang
Journal:  Cancer Med       Date:  2020-05-11       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.